Study on hypertensive patient's adherence to the treatment who attends three community pharmacies;Estudio sobre el cumplimiento terapéutico del paciente hipertenso que acude a tres farmacias comunitarias

Pharmaceutical Care Espana

Volumn 11, Issue 1, 2009, Pages 13-20

  Gaitán Benítez, M Montserrat ^a   Gracia Sánchez, M Candelaria ^a   Navarro Gonzalez D ^a  

^a Edificio Coblanca XV ^*

Author keywords

Adherence to treatment; High blood patient; Life style and community pharmacies; Patient compliance; Polypharmacy; Transversal study

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; CLINICAL PHARMACY; COMMUNITY; COMPLIANCE (PHYSICAL); CONTROLLED STUDY; DIET; DISEASE CONTROL; FEMALE; FUNCTION TEST; HUMAN; HYGIENE; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POLYPHARMACY; POPULATION;

EID: 77951541290     PISSN: None     EISSN: 11396202     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Braam RL, Van Uum SH, Lenders JW, Thien T. No response to antihypertensive therapy: consider non-adherence. Ned Tijdschr Geneeskd. 2007; 151(10): 569-573.
2. Frishman WH. Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens. Cardiol Rev. 2007; 15(5): 257-263.
3. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004; 19(4): 357-362. (Pubitemid 38916494)
4. Llisterri Caro JL, Rodríguez Roca LG, Alonso Moreno FJ, Lou Arnal S, División JA, Santos Rodríguez JA. Control de presión arterial en la población hipertensa española atendida en atención primaria. Estudio PRESCAP 2002. Med Clin (Barc). 2004: 122: 165-171.
5. Rodríguez Roca GC, Ariago Rodenas LM, Llisterri Cano JL, Alonso Moreno FJ, Banegas Banegas JR, Lou Arnal S. Control en la presión arterial en la población española de 65 años o más asistidos en atención primaria. Rev Esp Cardiol. 2005; 58: 359-366.
6. RottlaenderD, Scherner M, Scheneider T, Erdmann E. Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany. Dtsch Med Wochenschr. 2007; 132(4): 139-144. (Pubitemid 46405884)
7. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). December 2003. Hypertension. 2003; 42: 1.206.
8. Bolinder G, De Faire U. Ambulatory 24-h blood pressure monitoring in healthy, middle aged smokeless tobacco users, smokers, and nontabacco users. Am J Hypertens. 1999; 12(9 Pt 1): 948-949.
9. Gil Guillén V, Pedrera Carbonell V, Martínez Juan H, Merino Sánchez J. Hipertensión arterial en atención primaria. FMC. 1999; 6 Supl 3.
10. Xin X, He J, Frontini MG, et al. Effects of alcohol reduction on blood pressure. Hypertension. 2001; 38: 1.112-1.117.
11. Sudano I, Binggeli C, Spieker L, Lüscher TF, Ruschitzka F, Noll G, et al. Cardiovascular effects of coffee: is it a risk factor? Prog Cardiovasc Nurs. 2005; 20(2): 65-69.
12. Miller ER 3rd, Erlinger TP, Young DR, Jehn M, Charleston J, Rhodes D, et al. Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT). Hypertension. 2002; 40(5): 612-618.
13. Chobanian AV, Hill M. National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure: a critical review of current scientific evidence. Hypertension. 2000; 35: 858-863. (Pubitemid 30303940)
14. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al; DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001; 344(1): 3-10.
15. Millar GD, Di Rienzo DD, Reusser ME, McCarron DA. Benedit of dairy product consumption on blood pressure in humans: a summary of the biomedical literature. J Am Coll Nutr. 2000; 19 Supl 2: 147-164.
16. Maroto JM. Razones e inconvenientes. La utilización del ejercicio físico en el sujeto sano y en el cardiópata. Rev Lat Cardiol. 2000; 21: 69-73.
17. Kastarinen M, Laatikainen T, Salomaa V, Jousilahti P, Antikainen R, Tuomilehto J, et al. Trends in lifestyle factors affecting blood pressure in hypertensive and normotensive Finns during 1982-2002. J Hypertens. 2007; 25(2): 299-305.
18. Izdebska E, Cybulska I, Izdebskir J, Makowiecka-Ciesla M, Trzebski A. Effects of moderate physical training on blood pressure variability and hemodynamic pattern in mildly hypertensive subjects. J Physiol Pharmacol. 2004; 55(4): 713-724. (Pubitemid 40053040)
19. Burke V, Beilin LJ, Cutt HE, Mansour J, Williams A, Mori TA. A lifestyle program for treated hypertensives improved health-related behaviors and cardiovascular risk factors, a randomized controlled trial. J Clin Epidemiol. 2007; 60(2): 133-141. (Pubitemid 46039873)
20. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of self-reported measure of medication compliance. Med Care. 1986; 24: 67-74.
21. Piñeiro F, Gil V, Donis M, Orozco D, Pastor R, Merino J. Validez de 6 métodos indirectos para valorar el cumplimiento del tratamiento farmacológico en la hipertensión arterial. Aten Primaria. 1997; 19: 372-376. (Pubitemid 27280676)